fluoromisonidazole has been researched along with EHS Tumor in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (66.67) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chin, LK; Hofstrand, PD; Rasey, JS; Tewson, TJ | 1 |
| Griffiths, JR; Maxwell, RJ; Workman, P | 1 |
| Durand, RE; Grunbaum, Z; Krohn, KA; Magee, S; Nelson, NJ; Olive, PL; Rasey, JS | 1 |
3 other study(ies) available for fluoromisonidazole and EHS Tumor
| Article | Year |
|---|---|
Characterization of [18F]fluoroetanidazole, a new radiopharmaceutical for detecting tumor hypoxia.
Topics: Animals; Binding Sites; Blood-Brain Barrier; Cell Hypoxia; Chromatography, High Pressure Liquid; Contrast Media; Cricetinae; Cricetulus; Etanidazole; Female; Fibroblasts; Fibrosarcoma; Fluorine Radioisotopes; Glioma; Lung; Male; Mammary Neoplasms, Experimental; Mice; Mice, Inbred C3H; Misonidazole; Neoplasms, Experimental; Oxygen; Radionuclide Imaging; Radiopharmaceuticals; Rats; Sarcoma, Experimental; Time Factors; Tissue Distribution; Tumor Cells, Cultured | 1999 |
Demonstration of tumor-selective retention of fluorinated nitroimidazole probes by 19F magnetic resonance spectroscopy in vivo.
Topics: Animals; Magnetic Resonance Spectroscopy; Mammary Neoplasms, Experimental; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Misonidazole; Neoplasm Transplantation; Neoplasms, Experimental; Nitroimidazoles; Oxygen; Radiation-Sensitizing Agents; Sarcoma, Experimental | 1989 |
Characterization of radiolabeled fluoromisonidazole as a probe for hypoxic cells.
Topics: Animals; Autoradiography; Biotransformation; Carbon Radioisotopes; Cell Line; Chromatography, High Pressure Liquid; Chromatography, Thin Layer; Hypoxia; Mice; Mice, Inbred C3H; Misonidazole; Oxygen; Radionuclide Imaging; Sarcoma, Experimental; Tritium | 1987 |